The FRMD7 gene helps the brain and eyes work together to control steady eye movements. In medicine, this gene is important because it helps guide the development of nerve pathways that keep eye movements stable. If you carry a disease causing variant in the FRMD7 gene, the eyes may move on their own from early infancy, a condition called infantile nystagmus. This can make it harder to focus on faces, read, or judge distance, although symptoms vary from person to person.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes provide the code for proteins, which do much of the work inside cells. Others mainly guide when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and functions, and they can also shape your response to food, stress, and medications. More detailed information about this topic is available in the LearnHub.
Overview
FRMD7Gene function
What if the gene works
The FRMD7 gene helps nerve cells develop and connect in brain pathways that control eye movement. This supports steady gaze and smooth tracking.
Risk
What if the gene does not work
Variants in the FRMD7 gene can cause infantile nystagmus, with involuntary eye movements starting early in life and sometimes blurred vision. Effects range from milder to more severe, influencing how noticeable the movements are and how much sight is affected.
Treatment
What does that mean for your treatment
No FRMD7-specific treatment or medication choice is currently established for people with pathogenic variants in the FRMD7 gene. Research is exploring how the FRMD7 gene affects eye movement pathways, but this has not yet changed routine care.
Conditions associated with FRMD7
Gene function
What if the gene works
Smooth, coordinated eye movements depend on nerve cells building the right connections early in development. The FRMD7 gene supports that process by helping young nerve cells grow, shape their extensions, and connect in an organized way. This activity is especially important in brain and eye pathways that help the eyes move together.
FRMD7 helps developing nerve cells extend the long projections they use to reach other cells. This early growth supports the brain pathways needed for smooth, coordinated signaling.
Its protein helps organize actin (part of the cell's inner support framework). This gives growing nerve cells the shape and flexibility they need as they move and connect.
FRMD7 helps the tips of growing nerve cells respond to guidance cues from nearby tissue. This supports orderly wiring in circuits involved in steady eye movement control.
What is a variant?
Many genetic variants have no visible effect and are simply part of the natural differences seen between people. A genetic variant is a small change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Sometimes, though, a variant changes how a gene works more strongly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the FRMD7 gene can change the protein’s shape, stability, or position inside developing nerve cells, which may weaken neurite growth and the signaling needed for steady eye movements. Some variants only partly reduce function, while more disruptive changes can shorten the protein or stop cells from making it properly. This range helps explain how FRMD7 gene variants affect eye movement control and why infantile nystagmus can vary in onset and severity.
How variants are linked to conditions
Pathogenic variants in the FRMD7 gene cause X-linked infantile nystagmus, often called congenital or infantile nystagmus. In families looking into FRMD7 gene variants and infantile nystagmus, this is the main condition linked to the gene. It usually begins in early infancy and mainly affects eye movements and vision, while signs can vary from person to person and may be milder in some female carriers.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widespread in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a confirmed diagnosis, especially when several genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For FRMD7, risk is shaped mainly by whether a disease-causing change is inherited in the gene and, because it is on the X chromosome, whether the baby is male or female. Many males with a harmful FRMD7 change develop early eye movement problems, while females may have milder changes or no obvious symptoms.
Inheritance of FRMD7 variants
FRMD7-related conditions usually follow an X-linked inheritance pattern, which is the main FRMD7 inheritance pattern described in families with infantile nystagmus. If a mother carries a variant in the FRMD7 gene, each child has a 50% chance of inheriting it. Sons who inherit the variant are more likely to have symptoms, while daughters may have no symptoms or milder features. A father with a FRMD7 gene variant passes it to all of his daughters and none of his sons.
What does my FRMD7 result mean for my family?
FRMD7 results can matter for close relatives because changes in this gene are usually passed down on the X chromosome in families with infantile nystagmus, a condition that causes involuntary eye movements. Male relatives are more likely to have clear symptoms, while female relatives may have milder symptoms or may carry the change without noticing major vision problems. Brothers, sisters, children, and other relatives may also want to learn whether the same gene change is present in the family.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for FRMD7 variants uses a blood or saliva sample to read the DNA code of the FRMD7 gene and look for a variant that may explain infantile nystagmus (involuntary eye movements). Results can show whether a disease causing variant is present, absent, or uncertain, and they may also help clarify family testing.
When should I consider getting a genetic test?
Genetic testing for the FRMD7 gene may be worth considering if someone has repeated, uncontrolled eye movements that started in infancy or early childhood, especially when similar vision problems run in the family. A FRMD7 result can help confirm an inherited cause of childhood nystagmus and clarify family risk.
A genetic result is only one part of your health story
A genetic finding can provide useful information, but how much it explains depends on the condition and the kind of variant present. Over time, many factors, including lifestyle, environment, age, and medical history, affect how the body functions. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most helpful when considered alongside other parts of care. In other situations, a genetic finding may give a clear answer. In areas like medication response, genetic results can help place personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. A treatment that works well for one person may work less well for another, or may cause more side effects, because the body can absorb, break down, or respond to drugs in different ways. These differences are common and can influence how strongly a medicine works or how sensitive someone is to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect a person’s response to medications. It studies gene drug patterns to help explain why the same treatment may work differently from one person to another. For many drugs, genes can influence both how strongly a medicine works and how the body handles it. This information can support more informed and more personalized treatment decisions. To explore this subject in greater detail, you can learn more in the LearnHub.
Drugs influenced by the FRMD7 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how people respond to medicines, so general medication questions or new health concerns are best discussed with your doctor.
History
FRMD7 entered medical genetics through studies of families in which involuntary eye movements ran across generations, especially in patterns linked to the X chromosome. In 2006, researchers identified the FRMD7 gene as a cause of many cases of X linked infantile nystagmus, giving families a clearer explanation for a condition that had long been recognized by eye specialists. Initially understood only through visible traits, later recognized as tied to a specific gene, this discovery helped connect older clinical descriptions with modern genetic testing. From these first observations, research expanded steadily. Over time, scientists also found that not every family with infantile nystagmus has a change in FRMD7, which helped refine diagnosis and deepen understanding of inherited eye movement conditions.